GlassScriptPhysician profile
Elizabeth Beiter
NPI 1699979617
$2,100.11
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $154 · 2020: $296 · 2021: $169 · 2022: $469 · 2023: $540 · 2024: $472.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,012.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,011.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $555.48 | 2021-2024 | Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals LP | $265.34 | 2020-2024 | Airsupra |
| Dexcom, INC. | $214.28 | 2022-2023 | Dexcom G6 Transmitter |
| Pfizer INC. | $183.98 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $168.31 | 2019-2023 | Jardiance, Stiolto Respimat, Spiriva Respimat |
| Daiichi Sankyo INC. | $124.99 | 2020 | |
| Merck Sharp & Dohme LLC | $74.41 | 2019-2024 | Proquad, Vaxneuvance, Vaxelis |
| Abbvie INC. | $68.72 | 2019-2024 | Ubrelvy |
| Exact Sciences Corporation | $60.39 | 2023-2024 | Cologuard Collection Kit |
| Lilly USA, LLC | $57.28 | 2019-2024 | Mounjaro |
| Bayer Healthcare Pharmaceuticals INC. | $55.18 | 2023-2024 | |
| Phathom Pharmaceuticals, INC. | $50.83 | 2023-2024 | Voquezna |
| Glaxosmithkline, LLC. | $46.61 | 2019-2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $41.00 | 2022 | |
| Novo Nordisk INC | $38.97 | 2019-2023 | Wegovy |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $23.59 | 2024 | Veozah |
| Neurelis, INC. | $19.24 | 2024 | Valtoco |
| Xeris Pharmaceuticals, INC. | $16.10 | 2023 | Gvoke Hypopen |
| Horizon Therapeutics Plc | $12.79 | 2020 | |
| Sanofi Pasteur INC. | $11.51 | 2019 | |
| Amarin Pharma, INC. | $11.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Beiter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.